slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 93,631-93,660
Pages 3,685
Rows per page 30
Component
93,631-93,660 of 110,539
31
The slide uses a chevron-based process flow to map functional capabilities across the drug development lifecycle.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
36
Uses bubble charts to represent magnitude of growth over time.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
39
Evotec | Investor Presentation Deck | 49 slidesEvotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
46
Evotec | Investor Presentation Deck | 49 slidesEvotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
48
The slide uses a donut chart to visualize the ownership distribution.Evotec | Investor Presentation Deck | 49 slides · Evotec
Conference presentation Investor relations Beat · Action1 hit
03
The slide uses a split-screen layout to contrast internal R&D with external partnerships, unified by a central 'Multiple Discovery Programmes' icon stack.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · What Is1 hit
08
The slide uses a hub-and-spoke diagram centered on a human silhouette to represent the integration of clinical design, data generation, target identification, AI design, model-based learning, and biomarkers.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle1 hit
10
The slide uses a Gantt-style visualization for drug development stages.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Loop · Golden Circle1 hit
16
The slide uses a timeline framework to map partnership complexity against platform value.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
22
Uses information theory to illustrate exponential search space reduction.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Aha Moment1 hit
23
Uses a flywheel-like diagram to represent iterative learning cycles over time.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Aha Moment1 hit
28
The slide features a 3D molecular model and a dashboard of experimental metrics (Potency, Selectivity, CNS Barrier, Solubility, Cellular Potency, Stability, Permeability Ratio, Toxicity).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
30
The slide uses a pyramid framework to show the progression of data and process maturity.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
32
The diagram is a classic flywheel or continuous improvement loop.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
33
Includes a process flow diagram for Chemical Synthesis, Compound Management, and Biological Testing.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
35
The slide uses an isometric technical illustration to depict a modular lab setup.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
46
Exscientia | Investor Presentation Deck | 93 slidesExscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
49
The slide uses a human anatomy diagram to map specific cancer types to their locations, providing a visual representation of the addressable market.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
52
The slide uses a color-coded heatmap to visualize performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
53
Data source: Besnard et al, AACR (2022).Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
56
The slide uses a waterfall plot for single-agent sensitivity and a heatmap for combination synergy, highlighting specific patient response rates for different mechanisms of action.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
64
The slide uses a hub-and-spoke diagram to illustrate the interaction of LSD1 with various protein complexes, receptors, and RNAs.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
69
The table uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
70
The slide outlines a specific workflow involving generative design, ML, and active learning.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
71
The chart uses a scatter plot to visualize the Pareto front in drug discovery, highlighting the selection of compounds 1 and 2.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
72
The slide uses two distinct chart types (dot plot and line chart with error bars) to illustrate the safety profile of the drug candidate '539.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
74
The slide uses a heatmap to visualize synergy (green = yes, light green = no) across 6 drug combinations and 14 patient samples.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations Beat · Traction1 hit
77
The heatmap displays AUC values for 16 patient samples across three treatments.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
82
The slide uses a biological pathway diagram to illustrate the mechanism of action.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit
87
The slide highlights the application of computational chemistry (molecular dynamics) to drug discovery, specifically focusing on binding site analysis.Exscientia | Investor Presentation Deck | 93 slides · Exscientia
Pitch deck Investor relations 1 hit